payment

designer491 Ardelyx (NASDAQ:ARDX) stock tumbled 20% Tuesday morning after the company said it has decided not to apply to include its drug Xphozah in the US Centers for Medicare and Medicaid Services’ Transitional Drug Add-on Payment Adjustment, or TDAPA, program for certain renal disease drugs. The biotech company said inContinue Reading

NicoElNino/iStock via Getty Images CGI (NYSE:GIB) renewed its partnership with ExxonMobil (NYSE:XOM) for payment and loyalty services across Europe and the Asia Pacific region. CGI (GIB) will further enhance customization options for ExxonMobil and its customers through its fuel leading card payment solution, CGI PayPartner360. “This strategic approach not onlyContinue Reading